Which has preferable valuation & earnings, HQY or PINC?

HealthEquity has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.34B 6.55 $215.20M $2.67 39.22 Premier $1.00B 4.12 $20.27M -$0.27 N/A

Is HQY or PINC more profitable?

HealthEquity has a net margin of 17.25% compared to Premier's net margin of -3.28%. HealthEquity's return on equity of 14.75% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.25% 14.75% 9.22% Premier -3.28% 6.84% 3.48%

Which has higher earnings & valuation, PINC or OSCR?

Premier has higher earnings, but lower revenue than Oscar Health. Premier is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Premier $1.00B 4.12 $20.27M -$0.27 N/A Oscar Health $15.32B 0.66 -$443.15M $1.40 23.34

Is PINC or OSCR more profitable?

Oscar Health has a net margin of 3.60% compared to Premier's net margin of -3.28%. Oscar Health's return on equity of 38.45% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets Premier -3.28% 6.84% 3.48% Oscar Health 3.60% 38.45% 6.76%

Which has better earnings & valuation, PACS or PINC?

PACS Group has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.55B 1.27 $191.54M $1.72 25.95 Premier $1.00B 4.12 $20.27M -$0.27 N/A

Is PACS or PINC more profitable?

PACS Group has a net margin of 4.85% compared to Premier's net margin of -3.28%. PACS Group's return on equity of 29.55% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.85% 29.55% 5.23% Premier -3.28% 6.84% 3.48%

Which has stronger valuation & earnings, PINC or CHE?

Chemed has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Premier $1.00B 4.12 $20.27M -$0.27 N/A Chemed $2.53B 2.76 $265.24M $19.91 26.81

Is PINC or CHE more profitable?

Chemed has a net margin of 10.60% compared to Premier's net margin of -3.28%. Chemed's return on equity of 31.77% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets Premier -3.28% 6.84% 3.48% Chemed 10.60% 31.77% 18.90%

This company has been marked as potentially delisted and may not be actively trading.

Premier (PINC) Competitors

Compare

PINC vs. HQY, OSCR, PACS, CHE, and HIMS

Should you buy Premier stock or one of its competitors? Premier's main competitors and comparable companies include HealthEquity (HQY), Oscar Health (OSCR), PACS Group (PACS), Chemed (CHE), and Hims & Hers Health (HIMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Premier compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

HealthEquity has a net margin of 17.25% compared to Premier's net margin of -3.28%. HealthEquity's return on equity of 14.75% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Premier	-3.28%	6.84%	3.48%

HealthEquity has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 74.4% of Premier shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 1.0% of Premier shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

HealthEquity presently has a consensus price target of $110.93, suggesting a potential upside of 5.92%. Premier has a consensus price target of $26.46, suggesting a potential downside of 47.22%. Given HealthEquity's stronger consensus rating and higher probable upside, research analysts plainly believe HealthEquity is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Premier	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

HealthEquity has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.34B	6.55	$215.20M	$2.67	39.22
Premier	$1.00B	4.12	$20.27M	-$0.27	N/A

In the previous week, HealthEquity had 8 more articles in the media than Premier. MarketBeat recorded 8 mentions for HealthEquity and 0 mentions for Premier. HealthEquity's average media sentiment score of 1.02 beat Premier's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media.

Company	Overall Sentiment
HealthEquity	Positive
Premier	Neutral

Summary

HealthEquity beats Premier on 15 of the 16 factors compared between the two stocks.

How does Premier compare to Oscar Health?

Premier (NASDAQ:PINC) and Oscar Health (NYSE:OSCR) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Oscar Health had 18 more articles in the media than Premier. MarketBeat recorded 18 mentions for Oscar Health and 0 mentions for Premier. Oscar Health's average media sentiment score of 0.92 beat Premier's score of 0.00 indicating that Oscar Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Premier	Neutral
Oscar Health	Positive

Oscar Health has a net margin of 3.60% compared to Premier's net margin of -3.28%. Oscar Health's return on equity of 38.45% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Premier	-3.28%	6.84%	3.48%
Oscar Health	3.60%	38.45%	6.76%

74.4% of Premier shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 1.0% of Premier shares are held by company insiders. Comparatively, 22.6% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Premier has higher earnings, but lower revenue than Oscar Health. Premier is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Premier	$1.00B	4.12	$20.27M	-$0.27	N/A
Oscar Health	$15.32B	0.66	-$443.15M	$1.40	23.34

Premier has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.36, suggesting that its share price is 136% more volatile than the broader market.

Premier currently has a consensus price target of $26.46, suggesting a potential downside of 47.22%. Oscar Health has a consensus price target of $26.22, suggesting a potential downside of 19.76%. Given Oscar Health's stronger consensus rating and higher probable upside, analysts plainly believe Oscar Health is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Premier	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Oscar Health	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.42

Summary

Oscar Health beats Premier on 15 of the 17 factors compared between the two stocks.

How does Premier compare to PACS Group?

PACS Group (NYSE:PACS) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

PACS Group has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.55B	1.27	$191.54M	$1.72	25.95
Premier	$1.00B	4.12	$20.27M	-$0.27	N/A

74.4% of Premier shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 1.0% of Premier shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

PACS Group currently has a consensus target price of $56.00, indicating a potential upside of 25.49%. Premier has a consensus target price of $26.46, indicating a potential downside of 47.22%. Given PACS Group's stronger consensus rating and higher possible upside, analysts clearly believe PACS Group is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.00
Premier	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, PACS Group had 12 more articles in the media than Premier. MarketBeat recorded 12 mentions for PACS Group and 0 mentions for Premier. PACS Group's average media sentiment score of 0.62 beat Premier's score of 0.00 indicating that PACS Group is being referred to more favorably in the media.

Company	Overall Sentiment
PACS Group	Positive
Premier	Neutral

PACS Group has a net margin of 4.85% compared to Premier's net margin of -3.28%. PACS Group's return on equity of 29.55% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.85%	29.55%	5.23%
Premier	-3.28%	6.84%	3.48%

PACS Group has a beta of -0.08, suggesting that its share price is 108% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

Summary

PACS Group beats Premier on 14 of the 17 factors compared between the two stocks.

How does Premier compare to Chemed?

Premier (NASDAQ:PINC) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Chemed has a net margin of 10.60% compared to Premier's net margin of -3.28%. Chemed's return on equity of 31.77% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Premier	-3.28%	6.84%	3.48%
Chemed	10.60%	31.77%	18.90%

Chemed has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Premier	$1.00B	4.12	$20.27M	-$0.27	N/A
Chemed	$2.53B	2.76	$265.24M	$19.91	26.81

Premier has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market.

Premier currently has a consensus price target of $26.46, suggesting a potential downside of 47.22%. Chemed has a consensus price target of $530.75, suggesting a potential downside of 0.58%. Given Chemed's stronger consensus rating and higher probable upside, analysts plainly believe Chemed is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Premier	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

74.4% of Premier shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 1.0% of Premier shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Premier pays an annual dividend of $0.84 per share and has a dividend yield of 1.7%. Chemed pays an annual dividend of $2.40 per share and has a dividend yield of 0.4%. Premier pays out -311.1% of its earnings in the form of a dividend. Chemed pays out 12.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has increased its dividend for 16 consecutive years. Premier is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Chemed had 2 more articles in the media than Premier. MarketBeat recorded 2 mentions for Chemed and 0 mentions for Premier. Chemed's average media sentiment score of 1.76 beat Premier's score of 0.00 indicating that Chemed is being referred to more favorably in the news media.

Company	Overall Sentiment
Premier	Neutral
Chemed	Very Positive

Summary

Chemed beats Premier on 15 of the 19 factors compared between the two stocks.

How does Premier compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

Hims & Hers Health has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.58B	2.55	$128.37M	-$0.63	N/A
Premier	$1.00B	4.12	$20.27M	-$0.27	N/A

In the previous week, Hims & Hers Health had 56 more articles in the media than Premier. MarketBeat recorded 56 mentions for Hims & Hers Health and 0 mentions for Premier. Premier's average media sentiment score of 0.00 beat Hims & Hers Health's score of 0.00 indicating that Premier is being referred to more favorably in the news media.

Company	Overall Sentiment
Hims & Hers Health	Neutral
Premier	Neutral

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 1.0% of Premier shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Hims & Hers Health has a beta of 2.4, meaning that its stock price is 140% more volatile than the broader market. Comparatively, Premier has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

Premier has a net margin of -3.28% compared to Hims & Hers Health's net margin of -5.51%. Premier's return on equity of 6.84% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Premier	-3.28%	6.84%	3.48%

Hims & Hers Health currently has a consensus target price of $32.43, suggesting a potential upside of 15.21%. Premier has a consensus target price of $26.46, suggesting a potential downside of 47.22%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Hims & Hers Health is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Premier	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Hims & Hers Health beats Premier on 9 of the 16 factors compared between the two stocks.

Get Premier News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PINC vs. The Competition

Export

Metric	Premier	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.33B	$9.81B	$7.02B	$13.06B
Dividend Yield	2.97%	2.55%	2.57%	10.45%
P/E Ratio	-185.65	35.17	271.27	25.33
Price / Sales	4.12	4.70	583.72	76.93
Price / Cash	9.74	124.34	70.48	50.90
Price / Book	2.71	3.94	12.92	6.25
Net Income	$20.27M	$309.96M	$3.45B	$347.82M

Premier Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PINC Premier	N/A	$50.13 +77.9%	$26.46 -47.2%	+103.5%	$2.33B	$1.00B	N/A	2,700
HQY HealthEquity	4.0502 of 5 stars	$105.88 -0.9%	$110.93 +4.8%	+19.8%	$8.86B	$1.31B	39.69	2,814	Positive News
OSCR Oscar Health	4.406 of 5 stars	$27.68 +0.0%	$24.00 -13.3%	+122.5%	$8.35B	$11.70B	19.79	2,305	News Coverage Analyst Upgrade
PACS PACS Group	4.6327 of 5 stars	$46.20 -4.6%	$56.00 +21.2%	+286.0%	$7.32B	$5.29B	26.89	47,455	Positive News Insider Trade
CHE Chemed	4.1592 of 5 stars	$543.82 -1.0%	$530.75 -2.4%	+20.2%	$7.12B	$2.53B	27.36	15,811	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PINC) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Premier (PINC) Competitors

PINC vs. HQY, OSCR, PACS, CHE, and HIMS

How does Premier compare to HealthEquity?

Summary

How does Premier compare to Oscar Health?

Summary

How does Premier compare to PACS Group?

Summary

How does Premier compare to Chemed?

Summary

How does Premier compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PINC vs. The Competition

Premier Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Premier (PINC) Competitors

PINC vs. HQY, OSCR, PACS, CHE, and HIMS

How does Premier compare to HealthEquity?

Is HQY or PINC more profitable?

Which has more risk & volatility, HQY or PINC?

Do insiders and institutionals hold more shares of HQY or PINC?

Do analysts recommend HQY or PINC?

Which has preferable valuation & earnings, HQY or PINC?

Does the media prefer HQY or PINC?

Summary

How does Premier compare to Oscar Health?

Does the media refer more to PINC or OSCR?

Is PINC or OSCR more profitable?

Do institutionals & insiders hold more shares of PINC or OSCR?

Which has higher earnings & valuation, PINC or OSCR?

Which has more risk & volatility, PINC or OSCR?

Do analysts prefer PINC or OSCR?

Summary

How does Premier compare to PACS Group?

Which has better earnings & valuation, PACS or PINC?

Do institutionals & insiders believe in PACS or PINC?

Do analysts recommend PACS or PINC?

Does the media prefer PACS or PINC?

Is PACS or PINC more profitable?

Which has more volatility & risk, PACS or PINC?

Summary

How does Premier compare to Chemed?

Is PINC or CHE more profitable?

Which has stronger valuation & earnings, PINC or CHE?

Which has more volatility & risk, PINC or CHE?

Do analysts prefer PINC or CHE?

Do insiders & institutionals believe in PINC or CHE?

Is PINC or CHE a better dividend stock?

Does the media favor PINC or CHE?

Summary

How does Premier compare to Hims & Hers Health?

Which has stronger earnings & valuation, HIMS or PINC?

Does the media prefer HIMS or PINC?

Do institutionals and insiders have more ownership in HIMS or PINC?

Which has more risk & volatility, HIMS or PINC?

Is HIMS or PINC more profitable?

Do analysts rate HIMS or PINC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PINC vs. The Competition

Premier Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools